Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging?

Purpose To investigate the added value of post-contrast VIBE (volumetric-interpolated breath-hold examination) to PET/MR imaging for pulmonary nodule detection in patients with primary malignancies. Materials and Methods This retrospective institutional review board–approved study, with waiver of informed consent, included 51 consecutive patients who underwent 18F-fluorodeoxyglucose (FDG) PET/MR followed by PET/CT for cancer staging. In all patients, the thorax was examined with pre-and post-contrast VIBE MR with simultaneous PET acquisition. Two readers blinded to the patients’ data independently recorded their level of suspicion for pulmonary nodules based on PET, pre-contrast VIBE, and fused PET/MR images (first session), and reassessed them 4-weeks later after addition of post-contrast VIBE (second session). Jackknife alternative free-response receiver-operating-characteristic (JAFROC) analysis was performed, with PET/CT as the reference standard. Results A total of 151 pulmonary nodules (44 FDG-avid, 107 non-FDG-avid nodules) were detected on PET/CT, including 62 nodules≥5mm in diameter and 89 nodules<5mm. In the first session, the average nodule detection rate was 53.3% for all nodules, 97.7% for FDG-avid, 35.0% for non-FDG-avid nodules, 87.9% for nodules≥5mm and 29.2% for nodules<5mm. In the second session, the average detection rate was 53.3% for all nodules, 97.7% for FDG-avid, 35.0% for non-FDG-avid nodules, 85.5% for nodules≥5mm and 30.9% for nodules<5mm. The average JAFROC figure-of-merit was 0.837 in the first session and 0.848 in the second session. There were no significant differences in detection performance between sessions (P=0.48). Conclusion The addition of post-contrast VIBE to hybrid PET/MR imaging provided no additional value in the detection of pulmonary nodules.

[1]  Sebastian Fürst,et al.  PET/MR Imaging in the Detection and Characterization of Pulmonary Lesions: Technical and Diagnostic Evaluation in Comparison to PET/CT , 2014, The Journal of Nuclear Medicine.

[2]  G. Cheon,et al.  Positron Emission Tomography/Magnetic Resonance Imaging Evaluation of Lung Cancer: Current Status and Future Prospects , 2014, Journal of thoracic imaging.

[3]  C. Geppert,et al.  Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging. , 2013, Radiology.

[4]  J. L. Vercher-Conejero,et al.  N staging of lung cancer patients with PET/MRI using a three-segment model attenuation correction algorithm: Initial experience , 2013, European Radiology.

[5]  H. Alkadhi,et al.  Detection Rate, Location, and Size of Pulmonary Nodules in Trimodality PET/CT-MR: Comparison of Low-Dose CT and Dixon-Based MR Imaging , 2013, Investigative radiology.

[6]  A. Alavi,et al.  PET/MR imaging: technical aspects and potential clinical applications. , 2013, Radiology.

[7]  Markus Schwaiger,et al.  Workflow and Scan Protocol Considerations for Integrated Whole-Body PET/MRI in Oncology , 2012, The Journal of Nuclear Medicine.

[8]  C. Claussen,et al.  Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study. , 2012, Radiology.

[9]  R. Shah,et al.  Introducing Parametric Fusion PET/MRI of Primary Prostate Cancer , 2012, The Journal of Nuclear Medicine.

[10]  M. Puderbach,et al.  MRI of the lung (3/3)—current applications and future perspectives , 2012, Insights into Imaging.

[11]  Bernd J. Pichler,et al.  Feasibility of simultaneous PET/MR imaging in the head and upper neck area , 2011, European Radiology.

[12]  A. Dirksen,et al.  Preoperative staging of lung cancer with combined PET-CT. , 2009, The New England journal of medicine.

[13]  Dae Chul Jung,et al.  Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients. , 2009, European journal of cancer.

[14]  G Antoch,et al.  PET/CT for the staging and follow-up of patients with malignancies. , 2009, European journal of radiology.

[15]  F. Shellock,et al.  MRI safety update 2008: part 1, MRI contrast agents and nephrogenic systemic fibrosis. , 2008, AJR. American journal of roentgenology.

[16]  M Puderbach,et al.  MR imaging of the chest: a practical approach at 1.5T. , 2007, European journal of radiology.

[17]  I. Bradbury,et al.  Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. , 2007, Health technology assessment.

[18]  Hans-Ulrich Kauczor,et al.  Lung MRI at 1.5 and 3 Tesla: Observer Preference Study and Lesion Contrast Using Five Different Pulse Sequences , 2007, Investigative radiology.

[19]  A. Djamali,et al.  Nephrogenic systemic fibrosis: risk factors and incidence estimation. , 2007, Radiology.

[20]  C. Ganter,et al.  MRI of the lung: Value of different turbo spin‐echo, single‐shot turbo spin‐echo, and 3D gradient‐echo pulse sequences for the detection of pulmonary metastases , 2007, Journal of magnetic resonance imaging : JMRI.

[21]  Heinrich R Schelbert,et al.  Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Dev P Chakraborty,et al.  Analysis of location specific observer performance data: validated extensions of the jackknife free-response (JAFROC) method. , 2006, Academic radiology.

[23]  J. Debatin,et al.  Detection of pulmonary nodules using a 2D HASTE MR sequence: comparison with MDCT. , 2005, AJR. American journal of roentgenology.

[24]  Anthony J. Sherbondy,et al.  Pulmonary nodules on multi-detector row CT scans: performance comparison of radiologists and computer-aided detection. , 2005, Radiology.

[25]  Dev P Chakraborty,et al.  Observer studies involving detection and localization: modeling, analysis, and validation. , 2004, Medical physics.

[26]  G. V. von Schulthess,et al.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. , 2003, The New England journal of medicine.

[27]  C. Leutner,et al.  MRT des Lungenparenchyms , 2001 .

[28]  C. Leutner,et al.  [MRI of the lung parenchyma]. , 2001, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[29]  H. Kauczor,et al.  Contrast-enhanced MRI of the lung. , 2000, European journal of radiology.